Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray

NCT06497296 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.

NCT NCT06497296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray
Lead sponsor
National Cheng-Kung University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
December 31, 2024
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, tachycardia